Dostarlimab
Product Specifications
CAS Number
2022215-59-2
Target
PD-1/PD-L1
Related Pathways
Cell Cycle/Checkpoint, Apoptosis, Immunology/Inflammation
Purity
0.9892
Bioactivity
Dostarlimab (TSR-042) is a programmed cell death protein 1 (PD-1) receptor immune checkpoint inhibitor that blocks interactions with PD-L1 and PD-L2, used in the study of endometrial cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6331146-01 0.2 mL
PAX2, ID (PAX2, Paired box protein Pax-2) (FITC)
Sign In for Pricing
View Details